SINTX Technologies, Inc. (SINT), an advanced ceramics company specializing in biomedical applications of silicon nitride (SiN), Wednesday announced the publication of a study showing that silicon nitride exhibits strong antiviral activity against various infectious virus strains, including SARS-CoV-2 and MERS-CoV. Following the news, the company's shares were more than 20% up in pre-market.
The study, conducted in collaboration with Professor Kylene Kehn-Halls group at Virginia Polytechnic Institute and State University, showed that direct contact to alpha-phase silicon nitride reduced infectious SARS-CoV-2 titers by up to 99.97% within 10 minutes and inactivated completely by 30 minutes. Additionally, 97% inactivation was observed with contact to SiN when embedded in textile fabric widely used in a variety of medical devices and PPE products.
"These results arrive at a time when healthcare systems are actively seeking sustainable solutions to prevent future pandemics, combat antimicrobial resistance, and reduce healthcare-associated infections," said Eric Olson, Chief Executive Officer of SINTX Technologies. "As the only U.S.-based FDA-cleared and ISO-certified silicon nitride manufacturer, we are uniquely positioned to commercialize this technology in high-value markets where safety, efficacy, and scalability matter."
SINTX stock had closed at $4.57, up 10.12% on Tuesday. It has traded in the range of $1.7100 - $8.5960 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.